Search research articles
Contact Us
Filters
Showing results (61-70 of 384) with videos related to
Page
of 39
Sort By:
Seminars in Thrombosis and Hemostasis
|
October 1, 1991
Influence of hypersulfated lactobionic acid amides on tissue plasminogen activator release
H P Klöcking, A Hoffmann, J Fareed
Expert Opinion on Investigational Drugs
|
January 5, 2002
Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders
B Kaiser, D A Hoppensteadt, J Fareed
Expert Opinion on Investigational Drugs
|
July 5, 2005
Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders
B Kaiser, D H Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis
|
October 1, 1984
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A
J Amiral, J M Walenga, J Fareed
Headache
|
September 1, 1979
The nature of cluster headache
J L Medina, S Diamond, J Fareed
Thrombosis Research
|
August 15, 1985
Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway
L D Brace, S Issleib, J Fareed
Seminars in Thrombosis and Hemostasis
|
January 1, 1991
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspective
J M Walenga, D Hoppensteadt, J Fareed
Angiology
|
February 10, 1998
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report
B E Lewis, Y Rangel, J Fareed
Die Pharmazie
|
November 1, 2001
Antithrombin and anti-Xa agents in the control of thrombogenesis
J Fareed, T Shaikh, D A Hoppensteadt
Thrombosis Research
|
August 1, 1995
Effect of protamine on heparin releasable TFPI antigen levels in normal volunteers
D A Hoppensteadt, A Fasanella, J Fareed
Page
of 39
Search research articles
Search
Showing results (61-70 of 384) with videos related to
Sort By:
Page
of 39
Seminars in Thrombosis and Hemostasis
|
October 1, 1991
Influence of hypersulfated lactobionic acid amides on tissue plasminogen activator release
H P Klöcking, A Hoffmann, J Fareed
Expert Opinion on Investigational Drugs
|
January 5, 2002
Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders
B Kaiser, D A Hoppensteadt, J Fareed
Expert Opinion on Investigational Drugs
|
July 5, 2005
Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders
B Kaiser, D H Hoppensteadt, J Fareed
Seminars in Thrombosis and Hemostasis
|
October 1, 1984
Development and performance characteristics of a competitive enzyme immunoassay for fibrinopeptide A
J Amiral, J M Walenga, J Fareed
Headache
|
September 1, 1979
The nature of cluster headache
J L Medina, S Diamond, J Fareed
Thrombosis Research
|
August 15, 1985
Heparin-induced platelet aggregation is inhibited by antagonists of the thromboxane pathway
L D Brace, S Issleib, J Fareed
Seminars in Thrombosis and Hemostasis
|
January 1, 1991
Non-heparin glycosaminoglycan-derived drugs: a biochemical and pharmacologic perspective
J M Walenga, D Hoppensteadt, J Fareed
Angiology
|
February 10, 1998
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report
B E Lewis, Y Rangel, J Fareed
Die Pharmazie
|
November 1, 2001
Antithrombin and anti-Xa agents in the control of thrombogenesis
J Fareed, T Shaikh, D A Hoppensteadt
Thrombosis Research
|
August 1, 1995
Effect of protamine on heparin releasable TFPI antigen levels in normal volunteers
D A Hoppensteadt, A Fasanella, J Fareed
Page
of 39